Lemonade CEO-linked entity sells 126,625 shares
Lemonade, Inc. insider reporting shows that Dan and Dan Ltd., an entity controlled by Chief Executive Officer and director Daniel A. Schreiber, sold 126,625 shares of common stock on January 22, 2026.
Rhea-AI Filing Summary
Lemonade, Inc. insider reporting shows that Dan and Dan Ltd., an entity controlled by Chief Executive Officer and director Daniel A. Schreiber, sold 126,625 shares of common stock on January 22, 2026. The sale was made under a Rule 10b5-1 trading plan that was adopted on December 11, 2024, meaning the trades were pre-arranged according to preset instructions.
The filing reports a weighted average sale price of $94.74 per share, with the shares sold in multiple transactions. After this transaction, 1,523,534 shares of Lemonade common stock are reported as beneficially owned indirectly, held by Dan and Dan Ltd., over which Schreiber has voting and dispositive control.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | COMMON STOCK | 126,625 | $94.74 | $12.00M |
Footnotes (3)
- F1. Represents sale pursuant to a Rule 10b5-1 trading plan, adopted on December 11, 2024.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. The Reporting Person is Chief Executive Officer of Dan and Dan Ltd. ("Dan") and has voting and dispositive control over the shares held by Dan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the insider in this Lemonade (LMND) Form 4 filing?
What is the role of Dan and Dan Ltd. in this Lemonade (LMND) insider transaction?
Was this Lemonade (LMND) insider sale made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.